MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dystonia: Treatment"

  • 2025 International Congress

    Quality of life measurement in patients with generalized dystonia who underwent deep brain stimulation treatment.

    H. Pacheco, V. Gomez, C. Sánchez, L. Núñez (Mexico, Mexico)

    Objective: To measure the improvement in perceived Quality of Life (QoL) in patients who underwent to DBS placement. Background: Generalized dystonias are characterized by sustained…
  • 2025 International Congress

    Characteristics of IncobotulinumtoxinA Treatment for Cervical Dystonia in a Real-World Setting: Dosing and Muscles Injected

    J. Holmes, A. Kong, G. Askin, D. Nomah, D. Joseph, K. Biney, M. Hast (Raleigh, USA)

    Objective: To describe incobotulinumtoxinA doses and muscles injected in a real-world setting for patients with cervical dystonia (CD) Background: IncobotulinumtoxinA is approved to treat CD…
  • 2025 International Congress

    Deep Brain Stimulation in a Patient with Dystonia-Parkinsonism Secondary to a c.609G>A PLA2G6-Associated Neurodegeneration Variant

    J. Patino, M. Christie (Houston, USA)

    Objective: To describe a rare likely pathogenic variant of the PLA2G6 protein and its response to deep brain stimulation (DBS). Background: PLA2G6-associated neurodegeneration (PLAN) can…
  • 2025 International Congress

    Response to Bilateral GPi DBS in a Patient with DYT30

    N. Pulley, M. Luciano Palenzuela (San Francisco, USA)

    Objective: To describe the response of dystonia to deep brain stimulation (DBS) of the globus pallidus interna (GPi) in a patient with generalized dystonia due…
  • 2025 International Congress

    Telehealth Follow-up for Craniofacial Dystonias Treated with Neurotoxin Injection: Physician Outcomes

    K. Harper, L. Kopaeva, L. Venditti, J. Meystedt, M. Hacker, S. Sharp, P. Charles (Nashville, USA)

    Objective: To evaluate the potential benefits of a post-injection telehealth follow-up visit for people with craniofacial dystonia. Background: Craniofacial dystonias, including blepharospasm and oromandibular dystonia,…
  • 2025 International Congress

    Patient Perspectives on the Therapeutic Effects of Botulinum Toxin in Cervical Dystonia

    M. Relja, D. Dressler, F. Morgante, V. Trjulja (Zagreb, Croatia)

    Objective: To investigate patient perspectives on the therapeutic effects of botulinum toxin type-A  (BoNT-A) in cervical dystonia (CD) using patient s on-line survey. Background: CD…
  • 2025 International Congress

    Back Muscle Activity is Associated with Pain with Cervical Dystonia Patients

    R. Ortiz, M. Moisala, P. Maunu, J. Honkaniemi (Turku, Finland)

    Objective: To evaluate if dystonia patients without axial phenotype have spontaneous electric activity in back muscles. Background: Patients with cervical dystonia (CD) often complain of…
  • 2025 International Congress

    Case Report: Effect of DBS in a Patient with Cerebellar Atrophy

    A. Salisbury, A. Brucker, A. Zakharova, A. Mousavi, J. Maclean, J. Olaya, M. Liker, T. Sanger (Vitacura, Región Metropolitana, Chile)

    Objective: The aim of this study is to present the result of Deep Brain Stimulation in GPi (Globus pallidus internus) and VA (Ventral anterior nucleus of…
  • 2024 International Congress

    Pregnancy in Dystonia or Tourette’s patients with DBS. Eleven New Cases and a Review of the Literature.

    R. Mehanna, A. Tarakad, L. Taneff, E. Furr Stimming (Houston, USA)

    Objective: To review the available literature on pregnancy in patients who have received deep brain stimulation (DBS) for dystonia or Tourette’s syndrome (TS). Background: DBS…
  • 2024 International Congress

    DystoniaDBSNet: A novel deep learning biomarker of predictive treatment outcomes in dystonia

    DR. Yao, N. Sharma, K. Bhatia, E. Mulroy, J. Wong, Y. Yu, H. Akram, T. Foltynie, P. Limousin, L. Zrinzo, K. Simonyan (boston, USA)

    Objective: To develop an objective predictive measure of deep brain stimulation (DBS) treatment outcomes in dystonia. Background: Dystonia causes involuntary muscle contractions, affecting movements and…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 39
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • #28953 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley